Abstract
The purpose of this study was to test the relationship between biochemical and functional changes accompanying β-agonist induced cardiac hypertrophy and the activation of a calcium stimulated cysteine protease. Because the ultrastructural and ionic changes accompanying β-agonist induced cardiac hypertrophy are reminiscent of the actions of the calcium activated neutral protease, calpain, it was hypothesized that lowering calpain activity (by the use of an exogenous inhibitor(s)) would reduce the extent of hypertrophy. Rats (275-300 g) were randomly assigned to either a control, β-agonist (iso) or cysteine protease inhibitor (E64c) group. Isoproterenol administration (1 mg/kg) resulted in changes for ventricular weight to body weight ratio (↑19%), ventricular [RNA] (↑105.6%), rate of pressure development (↑22% for +dP/dt) and maximum developed left ventricular pressure (↑19%) (p < 0.05) after 3 days. Calpain-like activity (assessed by microplate method) increased by 45% (p < 0.05), while [cAMP] returned to control levels (following a transient rise at 1 day; 606.03 ± 124.1 pmol/g/wet/wt to 937.9 ± 225 (p < 0.05)). E64c (administered 1 h prior to iso) reduced the extent of hypertrophy, from 19 to 12%, and prevented the increases in; total [RNA], left ventricular function, the initial [cAMP] increase and calpain-like activity. It is concluded that a calcium stimulated cysteine protease(s), such as calpain, may be involved in the biochemical and functional changes associated with isoproterenol induced cardiac hypertrophy.
Similar content being viewed by others
References
Jacob R, Kissling G, Ebrecht G, Holubarsch C, Medugorac I, Rupp H: Adaptive and pathological alterations in experimental cardiac hyper-trophy. In: E Chazov, V Saks, G Rona (eds). Advances in Myo-cardiology. Vol 4. Plenum Publishing Corporation, 1983, pp 55-77
Morgan HE, Baker KM: Cardiac hypertrophy: Mechanical, neural, and endocrine dependence. Circ 83(1): 13-25, 1991
Winegrad S: Regulation of cardiac contractile proteins: Correlations between physiology and biochemistry. Circ Res 55(5): 565-574, 1984
VanDenhende R, Batnik HD, Michel MC, Vanzweiten PA: Influence of ischemia and reperfusion on cardiac signal transduction, G-protein content, adenylyl cyclase activity, cyclic AMP content, and forskolin and dibutryl cyclic AMP induced inotropy in the rat Langendorf heart. Fundam Clin Pharmacol 8: 408-416, 1994
Hassenfuss G, Mulieri LA, Leavitt BJ, Alpert NR: Influence of Isoproterenol on contractile protein function, excitation-contraction coupling, and energy turnover of isolated nonfailing human myocardium. J Mol Cell Cardiol 26: 1461-1469, 1994
Shah N, Than N, White E, Bennet KL, Orchard CH: The role of the sarcoplasmic reticulum in the response of isolated ferret muscle to β-adrenergic stimulation. Exp Physiol 79: 929-941, 1994
Hansen M, Rupp H: Cellular and molecular changes in the heart during stress and exercise. Methods Achieve Exp Pathol 15: 58-83, 1991
Hunter DR, Haworth RA, Berkoff HA: Measurement of rapidly exchangeable cellular calcium in the perfused beating rat heart. Proc Natl Acad Sci 78: 5665-5668, 1981
Watkins, Samuel SJ, Marlotte F, Bertier-Savalle B, Rappaport: Microtubules and desmin filaments during onset of hypertrophy in rat: A double immunoelectron microscope study. Circ Res 60: 327-336, 1987
Proud GC: Guanine nucleotide, protein phosphorylation and the control of translation. Trends Biochem Sci 11: 73-77, 1986
Gulch R, Baumann R, Jacob R: Analysis of myocardial action potential in left ventricular hypertrophy of Goldblatt rats. Basic Res Cardiol 74: 69-82, 1979
Toyo-Oka T, Morita M, Shin WS, Okai-Matsuo Y, Sugimoto T: Contribution of calcium activated neutral protease to the degradation process of ischemic heart. Jap Circ J 55: 1124-1126
Iizuka K, Kawaguchi H, Yasuda H: Calpain is activated by β-adrenergic receptor stimulation under hypoxic myocardial cell injury. Jap Circ J 55: 1086-1093, 1991
Belcastro AN: Skeletal muscle calcium-activated neutral protease (calpain) with exercise. J Appl Physiol 74(3): 1381-1386, 1993
Belcastro AN, Booker T, Raj DA: Are physiological-induced changes in muscle myeloperoxidase and calpain like activity correlated? (Abstract). J Mol Cell Cardiol 27(6): A261, 1995
Mehdi S: Cell penetrating inhibitors of calpain. TIBS 16: 149-153, 1991
Matsumura Y, Kusuoka H, Inoue M, Hori M, Kamada T: Protective effect of the protease inhibitor leupeptin against myocardial stunning. J Cardiovasc Pharmacol 22: 135-142, 1993
Bartus RT, Baker KL, Heiser AD, Sawyer SD, Dean RL, Elliot PJ, Straub JA: Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J Cereb Blood Flow Metab 14: 537-544, 1994
Benjamin IJ, Jalil JE, Tan LB, Cho K, Webber KT, Clark WA: Isoproterenol-induced myocardial fibrosis in relation to myocardial necrosis. Circ Res 65(3): 657-670, 1989
Chomcynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 162: 156-159, 1987.
Wang KKW, Villalabo A, Roufogalis BD: Calmodulin binding proteins as calpain substrates. Biochem. J. 262: 693-706, 1989
Gordon AL, Inchiosa, MA Jr, Lehr D: Isoproterenol-induced cardio-megaly: Assessment of myocardial protein content, actomyosin ATPase and heart rate. J Moll Cell Cardiol 4: 543-557, 1972
Tse J, Powell JR, Baste CA, Priest RE, Kuo JF: Isoproterenol-induced cardiac hypertrophy: Modifications in characteristics of b-adrenergic receptor, adenylate cyclase, and ventricular contraction. Endocrinology 105: 246-255, 1979
Brand T, Sharma HS, Scheper W: Expression of nuclear proto-oncogenes in isoproterenol induced cardiac hypertrophy. J Moll Cell Cardiol 25: 1325-1337, 1993
Van Bilsen M, Chien K: Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc Res 27: 1140-1149, 1993
Hannan RD, Luyken J, Rothblum LI: Regulation of ribosomal DNA transcription during contraction induced hypertrophy of neonatal cardiomyocytes. J Biol Chem 271(6): 3213-3220, 1996
Saido TC, Shibata M, Takenawa T, Murofushi H, Suzuki KJ: Positive regulation of m-calpain action by polyphosphoinositides. Biol Chem 267(34): 24585-24590, 1992
Endoh M: The effects of various drugs on the myocardial inotropic response. Gen Pharmacol 26(1): 1-31, 1995
Solaro RJ: Overview of the role of calcium and protein phosphorylation of the heart. In: RJ Solaro (ed). Protein Phosphorylation in Heart Muscle. CRE Press, Inc. Boca Raton, FL, pp 1-15
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arthur, G.D., Belcastro, A.N. A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy. Mol Cell Biochem 176, 241–248 (1997). https://doi.org/10.1023/A:1006857213829
Issue Date:
DOI: https://doi.org/10.1023/A:1006857213829